References
Key articles
United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the surgeon general. 2020 [internet publication].Full text Abstract
Fiore MC, Jaén CR, Baker TB, et al; US Department of Health and Human Services. Treating tobacco use and dependence: 2008 update. May 2008 [internet publication].Full text
US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021 Jan 19;325(3):265-79.Full text Abstract
Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2018 Dec 5;72(25):3332-65.Full text Abstract
Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;(5):CD000146.Full text Abstract
Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009 Feb;18(1):34-42.Full text Abstract
Reference articles
1. United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the surgeon general. 2020 [internet publication].Full text Abstract
2. Fiore MC, Jaén CR, Baker TB, et al; US Department of Health and Human Services. Treating tobacco use and dependence: 2008 update. May 2008 [internet publication].Full text
3. Maciosek MV, LaFrance AB, Dehmer SP, et al. Updated priorities among effective clinical preventive services. Ann Fam Med. 2017 Jan;15(1):14-22.Full text Abstract
4. Cornelius ME, Loretan CG, Wang TW, et al. Tobacco product use among adults - United States, 2020. MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):397-405.Full text Abstract
5. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021 Jun 19;397(10292):2337-60.Full text Abstract
6. Park-Lee E, Ren C, Cooper M, et al. Tobacco product use among middle and high school students - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1429-35.Full text Abstract
7. World Health Organization. Tobacco. May 2022 [internet publication].Full text
8. US Department of Health and Human Services. The health consequences of smoking - 50 years of progress. A report of the Surgeon General. Jan 2014 [internet publication].Full text
9. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-91.Full text Abstract
10. Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018 Jan 24;360:j5855.Full text Abstract
11. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004 Jun 26;328(7455):1519.Full text Abstract
12. Messer K, Pierce J, Zhu S-H, et al. The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation. Tob Control. 2007 Apr;16(2):85-90.Full text Abstract
13. Hummel K, Nagelhout GE, Fong GT, et al. Quitting activity and use of cessation assistance reported by smokers in eight European countries: findings from the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2018;16(2 suppl):A6.Full text Abstract
14. Beard E, Jackson SE, West R, et al. Trends in attempts to quit smoking in England since 2007: a time series analysis of a range of population-level influences. Nicotine Tob Res. 2020 Aug 24;22(9):1476-83. Abstract
15. Gravely S, Cummings KM, Hammond D, et al. Self-reported quit aids and assistance used by smokers at their most recent quit attempt: findings from the 2020 international tobacco control four country smoking and vaping survey. Nicotine Tob Res. 2021 Aug 29;23(10):1699-707.Full text Abstract
16. Lange S, Probst C, Rehm J, et al. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018 Jul;6(7):e769-76.Full text Abstract
17. Drake P, Driscoll AK, Mathews TJ. Cigarette smoking during pregnancy: United States, 2016. NCHS Data Brief. 2018 Feb;(305):1-8.Full text Abstract
18. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-94.Full text Abstract
19. US Department of Health and Human Services. Let's make the next generation tobacco-free: your guide to the 50th anniversary surgeon general's report on smoking and health. Jul 2015 [internet publication].Full text
20. Mays D, Gilman SE, Rende R, et al. Parental smoking exposure and adolescent smoking trajectories. Pediatrics. 2014 Jun;133(6):983-91. Abstract
21. Prom-Wormley EC, Clifford JS, Cooke ME, et al. The genetic and environmental influences contributing to the association between electronic and conventional cigarette initiation. Nicotine Tob Res. 2021 May 4;23(5):856-60. Abstract
22. Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014 Mar;71(3):248-54.Full text Abstract
23. Bandiera FC, Anteneh B, Le T, et al. Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One. 2015;10(3):e0120581.Full text Abstract
24. Ding JB, Hu K. Cigarette smoking and schizophrenia: etiology, clinical, pharmacological, and treatment implications. Schizophr Res Treatment. 2021;2021:7698030.Full text Abstract
25. Pacek LR, Cioe PA. Tobacco use, use disorders, and smoking cessation interventions in persons living with HIV. Curr HIV/AIDS Rep. 2015 Dec;12(4):413-20. Abstract
26. Gentzke AS, Wang TW, Cornelius M, et al. Tobacco product use and associated factors among middle and high school students - National Youth Tobacco Survey, United States, 2021. MMWR Surveill Summ. 2022 Mar 11;71(5):1-29.Full text Abstract
27. Donaldson SI, Dormanesh A, Escobedo P, et al. The impact of e-cigarette product place in music videos on susceptibility to use e-cigarettes among young adults: an experimental investigation. Addict Behav. 2022 Jul;130:107307. Abstract
28. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71. Abstract
29. Lindson N, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308.Full text Abstract
30. Loud EE, Duong HT, Henderson KC, et al. Addicted to smoking or addicted to nicotine? A focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non-smokers and dual users of cigarettes and e-cigarettes. Addiction. 2022 Feb;117(2):472-81. Abstract
31. Wold LE, Tarran R, Crotty Alexander LE, et al. Cardiopulmonary consequences of vaping in adolescents: a scientific statement from the American Heart Association. Circ Res. 2022 Jul 22;131(3):e70-82.Full text Abstract
32. European Lung Foundation; European Respiratory Society. E-cigarettes, heat-not-burn and smokeless tobacco products. Breathe (Sheff). 2020 Mar;16(1):161ELF.Full text Abstract
33. Perrine CG, Pickens CM, Boehmer TK, et al. Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):860-4.Full text Abstract
34. Rebuli ME, Rose JJ, Noël A, et al. The e-cigarette or vaping product use-associated lung injury epidemic: pathogenesis, management, and future directions: an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2023 Jan;20(1):1-17.Full text Abstract
35. Qasim H, Alarabi AB, Alzoubi KH, et al. The effects of hookah/waterpipe smoking on general health and the cardiovascular system. Environ Health Prev Med. 2019 Sep 14;24(1):58.Full text Abstract
36. Gravely S, Giovino GA, Craig L, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health. 2017 Apr;2(4):e166-74.Full text Abstract
37. Levy DT, Tam J, Kuo C, et al. The impact of implementing tobacco control policies: the 2017 tobacco control policy scorecard. J Public Health Manag Pract. 2018 Sep/Oct;24(5):448-57.Full text Abstract
38. National Institute on Drug Abuse. How can we prevent tobacco use? May 2022 [internet publication].Full text
39. Adachi-Mejia AM, Carlos HA, Berke EM, et al. A comparison of individual versus community influences on youth smoking behaviours: a cross-sectional observational study. BMJ Open. 2012;2(5):e000767.Full text Abstract
40. Warner KE. Tobacco control policies and their impacts. Past, present, and future. Ann Am Thorac Soc. 2014 Feb;11(2):227-30.Full text Abstract
41. Farrelly MC, Davis KC, Haviland ML, et al. Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health. 2005 Mar;95(3):425-31.Full text Abstract
42. Centers for Disease Control and Prevention. Tips from former smokers. Sep 2022 [internet publication].Full text
43. Murphy-Hoefer R, Davis KC, King BA, et al. Association between the tips from former smokers campaign and smoking cessation among adults, United States, 2012-2018. Prev Chronic Dis. 2020 Aug 27;17:E97.Full text Abstract
44. Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5):CD000165.Full text Abstract
45. US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021 Jan 19;325(3):265-79.Full text Abstract
46. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. Jan 2023 [internet publication].Full text
47. Swartz S, Hays J. Office-based intervention for tobacco dependence. Med Clin North Am. 2004 Nov;88(6):1623-41;xii-iii. Abstract
48. Polubriaginof F, Salmasian H, Albert DA, et al. Challenges with collecting smoking status in electronic health records. AMIA Annu Symp Proc. 2017;2017:1392-400.Full text Abstract
49. Rigotti NA, Kruse GR, Livingstone-Banks J, et al. Treatment of tobacco smoking: a review. JAMA. 2022 Feb 8;327(6):566-77. Abstract
50. Aveyard P, Massey L, Parsons A, et al. The effect of Transtheoretical Model based interventions on smoking cessation. Soc Sci Med. 2009 Feb;68(3):397-403. Abstract
51. Kim S. Overview of cotinine cutoff values for smoking status classification. Int J Environ Res Public Health. 2016 Dec 14;13(12):1236.Full text Abstract
52. Duchman KR, Gao Y, Pugely AJ, et al. The effect of smoking on short-term complications following total hip and knee arthroplasty. J Bone Joint Surg Am. 2015 Jul 1;97(13):1049-58. Abstract
53. Hart A, Rainer WG, Taunton MJ, et al. Cotinine testing improves smoking cessation before total joint arthroplasty. J Arthroplasty. 2019 Jul;34(7s):S148-51. Abstract
54. American Society of Addiction Medicine. Integrating tobacco use disorder interventions in addiction treatment. 2022 [internet publication].Full text
55. Fluharty M, Taylor AE, Grabski M, et al. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2017 Jan;19(1):3-13.Full text Abstract
56. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;(2):CD007253.Full text Abstract
57. Siskind DJ, Wu BT, Wong TT, et al. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis. Lancet Psychiatry. 2020 Sep;7(9):762-74. Abstract
58. Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2018 Dec 5;72(25):3332-65.Full text Abstract
59. Benowitz NL, Pipe A, West R, et al. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial. JAMA Intern Med. 2018 May 1;178(5):622-31.Full text Abstract
60. Soulakova JN, Hartman AM, Liu B, et al. Reliability of adult self-reported smoking history: data from the tobacco use supplement to the current population survey 2002-2003 cohort. Nicotine Tob Res. 2012 Aug;14(8):952-60. Abstract
61. Benowitz NL, Bernert JT, Foulds J, et al. Biochemical verification of tbacco use and abstinence: 2019 update. Nicotine Tob Res. 2020 Jun 12;22(7):1086-97.Full text Abstract
62. Lager PS, Attema-de Jonge ME, Gorzeman MP, et al. Clinical value of drugs of abuse point of care testing in an emergency department setting. Toxicol Rep. 2018;5:12-17.Full text Abstract
63. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
64. Aveyard P, West R. Managing smoking cessation. BMJ. 2007 Jul 7;335(7609):37-41.Full text Abstract
65. Jenssen BP, Walley SC, Boykan R, et al. Protecting children and adolescents from tobacco and nicotine. Pediatrics. 2023 May 1;151(5):e2023061805.Full text
66. Linder JA, Rigotti NA, Schneider LI, et al. An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med. 2009;169:781-787. Abstract
67. Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012 Jun;107(6):1066-73. Abstract
68. Borland R, Balmford J, Bishop N, et al. In-practice management versus quitline referral for enhancing smoking cessation in general practice: a cluster randomized trial. Fam Pract. 2008 Oct;25(5):382-9.Full text Abstract
69. American Academy of Family Physicians. Ask and act: a tobacco cessation program. 2010 [internet publication].Full text
70. Clair C, Mueller Y, Livingstone-Banks J, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2019 Mar 26;3(3):CD004705.Full text Abstract
71. Chamberlain C, O'Mara-Eves A, Porter J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017;(2):CD001055.Full text Abstract
72. Claire R, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD010078.Full text Abstract
73. Fanshawe TR, Halliwell W, Lindson N, et al. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017 Nov 17;(11):CD003289.Full text Abstract
74. Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017;(3):CD001007.Full text Abstract
75. Chen YF, Madan J, Welton N, et al. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technol Assess. 2012;16(38):1-205, iii-v.Full text Abstract
76. Taylor GMJ, Dalili MN, Semwal M, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017;(4):CD007078.Full text Abstract
77. Scott-Sheldon LA, Lantini R, Jennings EG, et al. Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis. JMIR Mhealth Uhealth. 2016 May 20;4(2):e49.Full text Abstract
78. Whittaker R, McRobbie H, Bullen C, et al. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019 Oct 22;10(10):CD006611.Full text Abstract
79. Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286.Full text Abstract
80. Kendzor DE, Businelle MS, Poonawalla IB, et al. Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment. Am J Public Health. 2015 Jun;105(6):1198-205.Full text Abstract
81. Notley C, Gentry S, Livingstone-Banks J, et al. Incentives for smoking cessation. Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD004307.Full text Abstract
82. Halpern SD, French B, Small DS, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015 May 28;372(22):2108-17.Full text Abstract
83. Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, et al. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2021 Jan 4;1:CD013229.Full text Abstract
84. Centers for Disease Control and Prevention. Tips from former smokers campaign: build your quit plan. Aug 2022 [internet publication].Full text
85. Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;(5):CD000146.Full text Abstract
86. Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009 Nov;66(11):1253-62.Full text Abstract
87. Office for Health Improvement and Disparities. Nicotine vaping in England: an evidence update including health risks and perceptions, 2022. Sep 2022 [internet publication].Full text
88. Hartmann-Boyce J, Lindson N, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. Abstract
89. US Food and Drug Administration. E-cigarettes, vapes, and other electronic nicotine delivery systems (ENDS). Jun 2022 [internet publication].Full text
90. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems; Eaton DL, Kwan LY, Stratton K. Public health consequences of e-cigarettes. Washington, DC: National Academies Press; 2018.Full text Abstract
91. Rose JJ, Krishnan-Sarin S, Exil VJ, et al. Cardiopulmonary impact of electronic cigarettes and vaping products: a scientific statement from the American Heart Association. Circulation. 2023 Aug 22;148(8):703-28.Full text Abstract
92. Cobb NK, Byron MJ, Abrams DB, et al. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health. 2010 Dec;100(12):2340-2.Full text Abstract
93. Public Health England (UK). Evidence review of e-cigarettes and heated tobacco products 2018: executive summary. Mar 2018 [internet publication].Full text
94. Stephens WE. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob Control. 4 Aug 2017 [Epub ahead of print].Full text Abstract
95. Herbst RS, Hatsukami D, Acton D, et al. Electronic Nicotine Delivery Systems: an updated policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. 2022 Dec 10;40(35):4144-55.Full text Abstract
96. Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;(5):CD006103.Full text Abstract
97. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-20. Abstract
98. Beard E, Jackson SE, Anthenelli RM, et al. Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors. Addiction. 2021;116(10):2816-24.Full text Abstract
99. Hughes J, Goldstein M, Hurt R, et al. Recent advances in the pharmacotherapy of smoking. JAMA. 1999 Jan 6;281(1):72-6. Abstract
100. Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009 Feb;18(1):34-42.Full text Abstract
101. Thomas KH, Dalili MN, López-López JA, et al. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Addiction. 2022 Apr;117(4):861-76.Full text Abstract
102. Windle SB, Filion KB, Mancini JG, et al. Combination therapies for smoking cessation: a hierarchical Bayesian meta-analysis. Am J Prev Med. 2016 Dec;51(6):1060-71. Abstract
103. Baker TB, Piper ME, Smith SS, et al. Effects of combined varenicline with nicotine patch and of extended treatment duration on smoking cessation: a randomized clinical trial. JAMA. 2021 Oct 19;326(15):1485-93.Full text Abstract
104. Shiffman S, Ferguson SG. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction. 2008 Apr;103(4):557-63. Abstract
105. Shiffman S, Ferguson SG, Strahs KR. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med. 2009 Feb;36(2):96-104;e1. Abstract
106. Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009 Apr 2;338:b1024.Full text Abstract
107. Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):687-94.Full text Abstract
108. Lindson N, Klemperer E, Hong B, et al. Smoking reduction interventions for smoking cessation. Cochrane Database Syst Rev. 2019 Sep 30;9(9):CD013183.Full text Abstract
109. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;(3):CD001292.Full text Abstract
110. Dietz PM, England LJ, Shapiro-Mendoza CK, et al. Infant morbidity and mortality attributable to prenatal smoking in the U.S. Am J Prev Med. 2010 Jul;39(1):45-52.Full text Abstract
111. American College of Obstetricians and Gynecologists. Tobacco and nicotine cessation during pregnancy: committee opinion, number 807. May 2020 [internet publication].Full text
112. Hickson C, Lewis S, Campbell KA, et al. Comparison of nicotine exposure during pregnancy when smoking and abstinent with nicotine replacement therapy: systematic review and meta-analysis. Addiction. 2019 Mar;114(3):406-24.Full text Abstract
113. Thomas RE, Baker PR, Thomas BC, et al. Family-based programmes for preventing smoking by children and adolescents. Cochrane Database Syst Rev. 2015;(2):CD004493.Full text Abstract
114. US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, et al. Primary care interventions for prevention and cessation of tobacco use in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2020 Apr 28;323(16):1590-8.Full text Abstract
115. Squeglia LM, Fadus MC, McClure EA, et al. Pharmacological treatment of youth substance use disorders. J Child Adolesc Psychopharmacol. 2019 Aug;29(7):559-72. Abstract
116. Bailey SR, Hagen SA, Jeffery CJ, et al. A randomized clinical trial of the efficacy of extended smoking cessation treatment for adolescent smokers. Nicotine Tob Res. 2013 Oct;15(10):1655-62.Full text Abstract
117. Myung SK, Park JY. Efficacy of pharmacotherapy for smoking cessation in adolescent smokers: a meta-analysis of randomized controlled trials. Nicotine Tob Res. 2019 Oct 26;21(11):1473-9. Abstract
118. Gray KM, Baker NL, McClure EA, et al. Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial. JAMA Pediatr. 2019 Dec 1;173(12):1146-53.Full text Abstract
119. Fiore MC, Goplerud E, Schroeder SA. The Joint Commission's new tobacco-cessation measures--will hospitals do the right thing? N Engl J Med. 2012 Mar 29;366(13):1172-4.Full text Abstract
120. Rigotti NA, Clair C, Munafò MR, et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012 May 16;5(5):CD001837. Abstract
121. Stefan MS, Pack Q, Shieh MS, et al. The association of nicotine replacement therapy with outcomes among smokers hospitalized for a major surgical procedure. Chest. 2020 May;157(5):1354-61. Abstract
122. Grønkjær M, Eliasen M, Skov-Ettrup LS, et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2014 Jan;259(1):52-71. Abstract
123. Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control. 2006 Oct;15(5):352-8. Abstract
124. Wong J, Abrishami A, Riazi S, et al. A perioperative smoking cessation intervention with varenicline, counseling, and fax referral to a telephone quitline versus a brief intervention: a randomized controlled trial. Anesth Analg. 2017 Aug;125(2):571-9.Full text Abstract
125. Warner DO. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology. 2006 Feb;104(2):356-67.Full text Abstract
126. Bernstein SL, D'Onofrio G, Rosner J, et al. Successful tobacco dependence treatment in low-income emergency department patients: a randomized trial. Ann Emerg Med. 2015 Aug;66(2):140-7.Full text Abstract
127. Hughes J. Depression during tobacco abstinence. Nicotine Tob Res. 2007 Apr;9(4):443-6. Abstract
128. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD010274.Full text Abstract
129. Guo K, Li J, Li J, et al. The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: a systematic review and meta-analysis of nine randomized controlled trials. Int J Clin Pract. 2021 Nov;75(11):e14594. Abstract
130. van Amsterdam J, van den Brink W. Smoking as an outcome moderator in the treatment of alcohol use disorders. Alcohol Alcohol. 2022 Nov 11;57(6):664-63.Full text Abstract
131. Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD004306.Full text Abstract
132. Nethan ST, Sinha DN, Chandan K, et al. Smokeless tobacco cessation interventions: a systematic review. Indian J Med Res. 2018 Oct;148(4):396-410.Full text Abstract
133. Nethan ST, Sinha DN, Sharma S, et al. Behavioral interventions for smokeless tobacco cessation. Nicotine Tob Res. 2020 Apr 17;22(4):588-93. Abstract
134. Maziak W, Jawad M, Jawad S, et al. Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev. 2015;(7):CD005549. Abstract
135. Howes S, Hartmann-Boyce J, Livingstone-Banks J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2020 Apr 22;4(4):CD000031.Full text Abstract
136. US Food and Drug Administration (FDA). FDA notice: varenicline (marketed as Chantix) and bupropion (marketed as Zyban, Wellbutrin, and generics) - Black Box warning. Jul 2009 [internet publication].
137. Jones SK, Wolf BJ, Froeliger B, et al. Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: a systematic review. Nicotine Tob Res. 2022 Mar 26;24(5):633-42.Full text Abstract
138. Jones SK, Wolf BJ, Froeliger B, et al. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation. Drug Alcohol Depend. 2022 Oct 1;239:109596. Abstract
139. Chen LS, Horton A, Bierut L. Pathways to precision medicine in smoking cessation treatments. Neurosci Lett. 2018 Mar 16;669:83-92. Abstract
140. Cornuz J, Zwahlen S, Jungi WF, et al. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One. 2008 Jun 25;3(6):e2547.Full text Abstract
141. Hartmann-Boyce J, Cahill K, Hatsukami D, et al. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012;(8):CD007072. Abstract
142. Celik M, Fuehrlein B. A review of immunotherapeutic approaches for substance use disorders: current status and future prospects. Immunotargets Ther. 2022;11:55-66.Full text Abstract
143. Saravia R, Ten-Blanco M, Pereda-Pérez I, et al. New insights in the involvement of the endocannabinoid system and natural cannabinoids in nicotine dependence. Int J Mol Sci. 2021 Dec 10;22(24):13316.Full text Abstract
144. Cahill K, Ussher M. Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database Syst Rev. 2011;(3):CD005353. Abstract
145. Galaj E, Xi ZX. Potential of cannabinoid receptor ligands as treatment for substance use disorders. CNS Drugs. 2019 Oct;33(10):1001-30. Abstract
146. Dinur-Klein L, Dannon P, Hadar A, et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol Psychiatry. 2014 Nov 1;76(9):742-9.Full text Abstract
147. Zangen A, Moshe H, Martinez D, et al. Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial. World Psychiatry. 2021 Oct;20(3):397-404.Full text Abstract
148. Barnes J, McRobbie H, Dong CY, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2019 Jun 14;6(6):CD001008.Full text Abstract
149. Wang JH, van Haselen R, Wang M, et al. Acupuncture for smoking cessation: a systematic review and meta-analysis of 24 randomized controlled trials. Tob Induc Dis. 2019;17:48.Full text Abstract
150. Bock BC, Dunsiger SI, Rosen RK, et al. Yoga as a complementary therapy for smoking cessation: results from BreathEasy, a randomized clinical trial. Nicotine Tob Res. 2019 Oct 26;21(11):1517-23. Abstract
151. Jackson S, Brown J, Norris E, et al. Mindfulness for smoking cessation. Cochrane Database Syst Rev. 2022 Apr 14;4(4):CD013696.Full text Abstract
152. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: smoking cessation [internet publication].Full text
153. Centers for Disease Control and Prevention. Smoking and tobacco use: clinical cessation tools. Dec 2021 [internet publication].Full text
154. Leone FT, Zhang Y, Evers-Casey S, et al. Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 Jul 15;202(2):e5-31.Full text Abstract
155. Canadian Task Force on Preventive Health Care. Tobacco smoking in children and adolescents. 2017 [internet publication].Full text
156. Registered Nurses' Association of Ontario. Integrating tobacco interventions into daily practice. Jun 2017 [internet publication].Full text
157. Hughes J, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004 Jan;99(1):29-38. Abstract
158. Livingstone-Banks J, Norris E, Hartmann-Boyce J, et al. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2019 Oct 28;2019(10):CD003999.Full text Abstract
159. Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction. 2009 Nov;104(11):1792-804.Full text Abstract
160. Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med. 2010 Feb 2;152(3):144-51.Full text Abstract
161. Cooney JL, Cooney NL, Pilkey DT, et al. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction. 2003 Jul;98(7):913-21. Abstract
162. Colby SM, Rohsenow DJ, Monti PM, et al. Effects of tobacco deprivation on alcohol cue reactivity and drinking among young adults. Addict Behav. 2004 Jul;29(5):879-92. Abstract
163. Aubin HJ, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012 Jul 10;345:e4439.Full text Abstract
164. Kim K, Park SM, Lee K. Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men. Eur Heart J. 2018 May 1;39(17):1523-31.Full text Abstract
165. Hartmann-Boyce J, Theodoulou A, Farley A, et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. Abstract
166. Yang M, Bhowmik D, Wang X, et al. Does combination pharmacological intervention for smoking cessation prevent post-cessation weight gain? A systemic review. Addict Behav. 2013 Mar;38(3):1865-75. Abstract
167. Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009 Jun;18(11):1533-40. Abstract
168. Wu AD, Lindson N, Hartmann-Boyce J, et al. Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. Abstract
169. van den Brand FA, Nagelhout GE, Reda AA, et al. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2017;(9):CD004305.Full text Abstract
170. Mills AL, Messer K, Gilpin EA, et al. The effect of smoke-free homes on adult smoking behavior: a review. Nicotine Tob Res. 2009 Oct;11(10):1131-41. Abstract
Use of this content is subject to our disclaimer